Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Puma Biotechnology, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +13 vs. Q3 2024
- Shares held
- 29.6M
- +1.02M (+3.6%) vs. Q3 2024
- Total value
- $90.1M
- +$17.3M (+23.8%) vs. Q3 2024
- New holders
- 28
- 46 more added
- Sold out
- 15
- 21 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBYI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 160 | $313.6M |
| Q1 2026 | 157 | $241.8M |
| Q4 2025 | 151 | $210.2M |
| Q3 2025 | 132 | $182.6M |
| Q2 2025 | 121 | $112.8M |
| Q1 2025 | 116 | $90.1M |
| Q4 2024 | 112 | $90.1M |
| Q3 2024 | 100 | $76.0M |
| Q2 2024 | 99 | $101.0M |
| Q1 2024 | 93 | $164.4M |
| Q4 2023 | 82 | $117.0M |
| Q3 2023 | 69 | $67.6M |
| Q2 2023 | 68 | $93.8M |
| Q1 2023 | 78 | $86.3M |
| Q4 2022 | 89 | $116.3M |
| Q3 2022 | 83 | $65.5M |
| Q2 2022 | 89 | $79.5M |
| Q1 2022 | 104 | $86.1M |
| Q4 2021 | 102 | $93.1M |
| Q3 2021 | 116 | $226.0M |
| Q2 2021 | 120 | $319.3M |
| Q1 2021 | 118 | $355.9M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Puma Biotechnology, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 609,942 | $1.86M | 0.00% | +8,400+1.4% | Added |
| Kennedy Capital Management, Inc. | 809,375 | $2.47M | 0.05% | +216,329+36.5% | Added |
| Dimensional Fund Advisors LP | 863,760 | $2.64M | 0.00% | +170,968+24.7% | Added |
| Geode Capital Management, LLC | 919,435 | $2.80M | 0.00% | +2,068+0.2% | Added |
| American Century Companies Inc | 948,376 | $2.89M | 0.00% | +73,833+8.4% | Added |
| Eversept Partners, LP | 996,102 | $3.04M | 0.31% | −297,155−23.0% | Reduced |
| Renaissance Technologies LLC | 1,755,513 | $5.35M | 0.01% | −16,900−1.0% | Reduced |
| Millennium Management LLC | 1,894,126 | $5.78M | 0.01% | −986,762−34.3% | Reduced |
| Acadian Asset Management LLC | 1,972,128 | $6.01M | 0.02% | +3,129+0.2% | Added |
| Vanguard Group Inc | 3,643,422 | $11.1M | 0.00% | +7,231+0.2% | Added |
| BlackRock, Inc. | 3,823,805 | $11.7M | 0.00% | −3,418−0.1% | Reduced |
| Acorn Capital Advisors, LLC | 3,940,052 | $12.0M | 6.47% | +3,940,052 | New |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −3,062,558−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −35,097−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −30,905−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,509−100.0% | Sold out |
| Buckingham Strategic Partners | 0 | $0 | 0.00% | −19,235−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −17,366−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,173−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,790−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,695−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −4,611−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −667−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Athyrium Capital Management, LP | – | – | – | – | Not filed |